In conclusion, these results showed that the markedly and consistently increasing expression of nucleolin may be associated with aggressive characteristics of HCC, and implied that nucleolin expression may serve as a promising biochemical marker for predicting the clinical outcome of patients with this malignancy. The gene discussed is NUCLEOLIN; the disease is hepatocellular carcinoma.